BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29017699)

  • 1. Urinary calcium excretion and bone turnover in osteoporotic patients
.
    El-Husseini A; Chakraborty A; Yuan Q; Inayatullah S; Bush H; Sawaya BP
    Clin Nephrol; 2017 Nov; 88(11):239-247. PubMed ID: 29017699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass.
    Park SM; Joung JY; Cho YY; Sohn SY; Hur KY; Kim JH; Kim SW; Chung JH; Lee MK; Min YK
    Eur J Clin Nutr; 2015 Mar; 69(3):361-6. PubMed ID: 25649239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
    Abdalbary M; Chishti E; Shakhashiro M; Mohamed R; Parikh T; Nassar MK; Sayed-Ahmed N; Faugere MC; Sawaya BP; El-Husseini A
    Osteoporos Int; 2023 Apr; 34(4):763-774. PubMed ID: 36790470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractional calcium absorption is increased in girls with Rett syndrome.
    Motil KJ; Schultz RJ; Abrams S; Ellis KJ; Glaze DG
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):419-26. PubMed ID: 16641581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.
    Arrabal-Polo MA; Girón-Prieto MS; Cano-García Mdel C; Poyatos-Andujar A; Quesada-Charneco M; Abad-Menor F; Arias-Santiago S; Zuluaga-Gomez A; Arrabal-Martin M
    Urology; 2015 Apr; 85(4):782-5. PubMed ID: 25817102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of resveratrol on bone metabolism and bone turnover related indexes in ovariectomized osteoporosis rats.
    Zhang Y; Deng L; Fan J; Zhang Y
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):92-97. PubMed ID: 33040820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The course of hypercalciuria and related markers of bone metabolism parameters associated with corticosteroid treatment.
    Duzen O; Erkoc R; Begenik H; Soyoral YU; Aldemir MN
    Ren Fail; 2012; 34(3):338-42. PubMed ID: 22260330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
    Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
    Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily oral magnesium supplementation suppresses bone turnover in young adult males.
    Dimai HP; Porta S; Wirnsberger G; Lindschinger M; Pamperl I; Dobnig H; Wilders-Truschnig M; Lau KH
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2742-8. PubMed ID: 9709941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure.
    Coen G; Mantella D; Calabria S; Sardella D; Manni M; Fassino V; D'Anello E; Giustini M; Taggi F
    Am J Nephrol; 2000; 20(4):283-90. PubMed ID: 10970981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary calcium and bone turnover markers].
    de la Torre Vega JP; Amador Licona N; Zamora Mata L; Morales Ramos Ael J
    Ginecol Obstet Mex; 2004 Jan; 72(1):23-8. PubMed ID: 15239561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study.
    Hekimian G; Boutten A; Flamant M; Duval X; Dehoux M; Benessiano J; Huart V; Dupré T; Berjeb N; Tubach F; Iung B; Vahanian A; Messika-Zeitoun D
    Eur Heart J; 2013 Jul; 34(25):1915-22. PubMed ID: 23329150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.